150 related articles for article (PubMed ID: 31262359)
1. Adverse drug reactions experienced by out-patients taking chlorpromazine or haloperidol at Zomba Mental Hospital, Malawi.
Chikowe I; Domingo M; Mwakaswaya V; Parveen S; Mafuta C; Kampira E
BMC Res Notes; 2019 Jul; 12(1):376. PubMed ID: 31262359
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of clozapine, haloperidol and chlorpromazine in schizophrenia during a five-year period.
Ravanic DB; Dejanovic SM; Janjic V; Jovic SD; Milovanovic DR; Jakovljevic V; Pantovic V; Ravanic B; Pantovic M; Pantovic MM
Arq Neuropsiquiatr; 2009 Jun; 67(2A):195-202. PubMed ID: 19547808
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of the concept of relative potency: an example involving chlorpromazine and haloperidol.
Preskorn SH
J Psychiatr Pract; 2005 Jul; 11(4):258-61. PubMed ID: 16041236
[No Abstract] [Full Text] [Related]
4. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
Sramek JJ; Simpson GM; Morrison RL; Heiser JF
J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
[TBL] [Abstract][Full Text] [Related]
6. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
István S; Agoston T; Tamás T; Zoltán J
Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
8. [Cytolytic hepatitis during treatment with phenothiazines: apropos of a case].
Mesure G; Bayle F; Vanelle JM; Olié JP; Lôo H
Encephale; 1996; 22(5):388-90. PubMed ID: 9035996
[TBL] [Abstract][Full Text] [Related]
9. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
[TBL] [Abstract][Full Text] [Related]
10. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
[TBL] [Abstract][Full Text] [Related]
11. Risk of Mortality Among Patients Treated With Antipsychotic Medications: A Nationwide Population-Based Study in Taiwan.
Wang LJ; Lee SY; Yuan SS; Yang KC; Yang CJ; Lee TL; Shyu YC
J Clin Psychopharmacol; 2016 Feb; 36(1):9-17. PubMed ID: 26658260
[TBL] [Abstract][Full Text] [Related]
12. First generation antipsychotic-induced severe hypothermia: A case report and review of the literature.
Elbakary NAH; Ouanes S
Asian J Psychiatr; 2019 Aug; 44():35-37. PubMed ID: 31306860
[No Abstract] [Full Text] [Related]
13. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Powney MJ; Adams CE; Jones H
Cochrane Database Syst Rev; 2012 Nov; 11():CD009377. PubMed ID: 23152276
[TBL] [Abstract][Full Text] [Related]
14. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Reschke RW
Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
[TBL] [Abstract][Full Text] [Related]
15. Haloperidol versus chlorpromazine for schizophrenia.
Leucht C; Kitzmantel M; Chua L; Kane J; Leucht S
Cochrane Database Syst Rev; 2008 Jan; (1):CD004278. PubMed ID: 18254045
[TBL] [Abstract][Full Text] [Related]
16. Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.
Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano R; O'Gorman C; Harrigan RH
Pharmacotherapy; 2010 Feb; 30(2):127-35. PubMed ID: 20099987
[TBL] [Abstract][Full Text] [Related]
17. Chlorpromazine for psychosis induced aggression or agitation.
Ahmed U; Jones H; Adams CE
Cochrane Database Syst Rev; 2010 Apr; (4):CD007445. PubMed ID: 20393959
[TBL] [Abstract][Full Text] [Related]
18. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
[TBL] [Abstract][Full Text] [Related]
19. Parenteral haloperidol in psychiatric emergencies. Double-blind comparison with chlorpromazine.
Gerstenzang ML; Krulisky TV
Dis Nerv Syst; 1977 Aug; 38(8):581-3. PubMed ID: 328243
[TBL] [Abstract][Full Text] [Related]
20. Body weight gain induced by a newer antipsychotic agent reversed as negative symptoms improved.
Koga M; Nakayama K
Acta Psychiatr Scand; 2005 Jul; 112(1):75-6; discussion 77. PubMed ID: 15952949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
